Keratinocytcancer

Emilie Westerlin Kjeldsen; Vinzent Kevin  Ortner; Ann-Kathrine Rossau; Gabrielle Randskov Vinding; Henrik Lorentzen; Henrik Sølvsten; Katrine Togsverd-Bo; Kristine Pallesen; Peter Bjerring; Trine Høgsberg; Ulrikke Lei; Merete Hædersdal

doi:10.61409/V10240733

Keratinocytcancer

Translated title of the contribution: Keratinocyte cancer

Emilie Westerlin Kjeldsen
, Vinzent Kevin Ortner
, Ann-Kathrine Rossau
, Gabrielle Randskov Vinding
, Henrik Lorentzen
, Henrik Sølvsten
, Katrine Togsverd-Bo
, Kristine Pallesen
, Peter Bjerring
, Trine Høgsberg
, Ulrikke Lei
, Merete Hædersdal^*

^*Corresponding author for this work

Dermatology

Research output: Contribution to journal › Review › Research › peer-review

Abstract

Keratinocyte cancer (KC) cases have risen by 172% in Denmark over the last decade and the lifetime risk of developing KC is at least 22%. This highlights the need for innovative strategies in KC prevention, diagnosis, and treatment. To reduce incidence, new prevention methods are crucial. New diagnostics using non-invasive scanning can streamline patient care, especially for low-risk tumours and patients with multiple tumours. New treatments can be more effective and with fewer side effects. Together, these initiatives can improve the patient journey and ease the burden on healthcare resources, as argued in this review.

Translated title of the contribution	Keratinocyte cancer
Original language	Danish
Article number	V10240733
Number of pages	8
Journal	Ugeskrift for Laeger
Volume	187
Issue number	14
DOIs	https://doi.org/10.61409/V10240733
Publication status	Published - 31 Mar 2025

Access to Document

10.61409/V10240733

https://content.ugeskriftet.dk/sites/default/files/V10240733_WEB.pdfLicence: CC BY-NC-ND

Cite this

@article{0b174e6dcd974d5ba602c2d61b5d24c1,

title = "Keratinocytcancer",

abstract = "Keratinocyte cancer (KC) cases have risen by 172\% in Denmark over the last decade and the lifetime risk of developing KC is at least 22\%. This highlights the need for innovative strategies in KC prevention, diagnosis, and treatment. To reduce incidence, new prevention methods are crucial. New diagnostics using non-invasive scanning can streamline patient care, especially for low-risk tumours and patients with multiple tumours. New treatments can be more effective and with fewer side effects. Together, these initiatives can improve the patient journey and ease the burden on healthcare resources, as argued in this review.",

keywords = "Carcinoma, Basal Cell/epidemiology, Denmark/epidemiology, Humans, Incidence, Keratinocytes/pathology, Keratoconus/epidemiology, Registries, Risk, Skin Neoplasms/epidemiology",

author = "Kjeldsen, \{Emilie Westerlin\} and Ortner, \{Vinzent Kevin\} and Ann-Kathrine Rossau and Vinding, \{Gabrielle Randskov\} and Henrik Lorentzen and Henrik S{\o}lvsten and Katrine Togsverd-Bo and Kristine Pallesen and Peter Bjerring and Trine H{\o}gsberg and Ulrikke Lei and Merete H{\ae}dersdal",

note = "Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.",

year = "2025",

month = mar,

day = "31",

doi = "10.61409/V10240733",

language = "Dansk",

volume = "187",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "14",

}

TY - JOUR

T1 - Keratinocytcancer

AU - Kjeldsen, Emilie Westerlin

AU - Ortner, Vinzent Kevin

AU - Rossau, Ann-Kathrine

AU - Vinding, Gabrielle Randskov

AU - Lorentzen, Henrik

AU - Sølvsten, Henrik

AU - Togsverd-Bo, Katrine

AU - Pallesen, Kristine

AU - Bjerring, Peter

AU - Høgsberg, Trine

AU - Lei, Ulrikke

AU - Hædersdal, Merete

N1 - Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.

PY - 2025/3/31

Y1 - 2025/3/31

N2 - Keratinocyte cancer (KC) cases have risen by 172% in Denmark over the last decade and the lifetime risk of developing KC is at least 22%. This highlights the need for innovative strategies in KC prevention, diagnosis, and treatment. To reduce incidence, new prevention methods are crucial. New diagnostics using non-invasive scanning can streamline patient care, especially for low-risk tumours and patients with multiple tumours. New treatments can be more effective and with fewer side effects. Together, these initiatives can improve the patient journey and ease the burden on healthcare resources, as argued in this review.

AB - Keratinocyte cancer (KC) cases have risen by 172% in Denmark over the last decade and the lifetime risk of developing KC is at least 22%. This highlights the need for innovative strategies in KC prevention, diagnosis, and treatment. To reduce incidence, new prevention methods are crucial. New diagnostics using non-invasive scanning can streamline patient care, especially for low-risk tumours and patients with multiple tumours. New treatments can be more effective and with fewer side effects. Together, these initiatives can improve the patient journey and ease the burden on healthcare resources, as argued in this review.

KW - Carcinoma, Basal Cell/epidemiology

KW - Denmark/epidemiology

KW - Humans

KW - Incidence

KW - Keratinocytes/pathology

KW - Keratoconus/epidemiology

KW - Registries

KW - Risk

KW - Skin Neoplasms/epidemiology

U2 - 10.61409/V10240733

DO - 10.61409/V10240733

M3 - Review

C2 - 40171911

SN - 0041-5782

VL - 187

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 14

M1 - V10240733

ER -

Keratinocytcancer

Abstract

Access to Document

Fingerprint

Cite this